Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice

Sajjad Hussain, Tibor Bedekovics, Qiuying Liu, Wenqian Hu, Haeseung Jeon, Sarah H. Johnson, George Vasmatzis, Danielle G. May, Kyle J. Roux, Paul J. Galardy

Blood (2018) 132 (24): 2564–2574.

https://doi.org/10.1182/blood-2018-05-848515

Published: 2018

Includes: Supplemental data

Journal Articles

Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis

Tibor Bedekovics, PhD, Sajjad Hussain, PhD MSC, Paul J. Galardy, MD

Blood (2017) 130 (Supplement 1): 644.

https://doi.org/10.1182/blood.V130.Suppl_1.644.644

Published: 2017

Journal Articles

UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma

Tibor Bedekovics, Sajjad Hussain, Andrew L. Feldman, Paul J. Galardy

Blood (2016) 127 (12): 1564–1574.

https://doi.org/10.1182/blood-2015-07-656678

Published: 2016

Includes: Supplemental data

Journal Articles

UCH-L1 Cooperates with BCL6 and Identifies Patients with Aggressive Germinal Center Diffuse Large B-Cell Lymphoma

Tibor Bedekovics, PhD, Sajjad Hussain, PhD, Andrew L Feldman, MD, Paul J. Galardy, MD

Blood (2015) 126 (23): 2673.

https://doi.org/10.1182/blood.V126.23.2673.2673

Published: 2015

Journal Articles

UCHL1 Is a Biomarker of Aggressive Multiple Myeloma Required for Disease Progression

Sajjad Hussain, PhD, Tibor Bedekovics, PhD, Marta Chesi, PhD, Leif Bergsagel, MD PhD, Paul J. Galardy, MD

Blood (2015) 126 (23): 2980.

https://doi.org/10.1182/blood.V126.23.2980.2980

Published: 2015

Journal Articles

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

Sajjad Hussain, PhD, Steven C. Ziesmer, Andrew L. Feldman, MD, Stephen M. Ansell, MD, PhD, Paul J. Galardy, MD

Blood (2011) 118 (21): 3691.

https://doi.org/10.1182/blood.V118.21.3691.3691

Published: 2011

Journal Articles

UCH-L1, a Potent Oncogene That Drives the Development of B-Cell Lymphoma, Promotes Akt Signaling by Regulating Mtor Complex Assembly

Sajjad Hussain, PhD, Paul J. Galardy, MD

Blood (2010) 116 (21): 4182.

https://doi.org/10.1182/blood.V116.21.4182.4182

Published: 2010

Journal Articles

UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation.

Sajjad Hussain, PhD, Paul J. Galardy, MD

Blood (2008) 112 (11): 3338.

https://doi.org/10.1182/blood.V112.11.3338.3338

Published: 2008

NARROW

UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice

Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis

UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma

UCH-L1 Cooperates with BCL6 and Identifies Patients with Aggressive Germinal Center Diffuse Large B-Cell Lymphoma

UCHL1 Is a Biomarker of Aggressive Multiple Myeloma Required for Disease Progression

UCH-L1 Is a Novel Regulator of mTOR Signaling That May Predict a Poor Response to mTOR Inhibition in Patients with B-Cell Lymphoma,

UCH-L1, a Potent Oncogene That Drives the Development of B-Cell Lymphoma, Promotes Akt Signaling by Regulating Mtor Complex Assembly

UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only